Elliot Tapper's Avatar

Elliot Tapper

@ebtapper.bsky.social

Hepatologist. #LiverSky / LiverLand. #MedSky. #cirrhosis Academic Chief of Hepatology at University of Michigan. Editor, Hepatology Communications. Kid Chauffeur

2,499 Followers  |  439 Following  |  502 Posts  |  Joined: 01.09.2023  |  2.0722

Latest posts by ebtapper.bsky.social on Bluesky

Post image Post image

1 in 5 Greek puppies with chronic kidney disease have advanced liver disease and it is the liver disease that is most linked to poor quality of life

30.08.2025 00:52 β€” πŸ‘ 5    πŸ” 0    πŸ’¬ 2    πŸ“Œ 0
Preview
Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies Disproportionate increases in retail prices for the cheapest beverages, beer and spirits, might lead to a greater decline in consumption among high-risk groups. Pricing policies could thus be used as ...

New at The Lancet Public Health - Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies

www.thelancet.com/journals/lan...

#alcohol #LiverSky #MedSky

28.08.2025 10:23 β€” πŸ‘ 1    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
PSC Grant Application | Liver Research Grants | PSC Partners Seeking a Cure Are you researching PSC? Do you need your medical research funded? At PSC Partners, we award grants to researchers answering important questions related to PSC. Apply.

Dear #LiverSky #HepatoSky researchers:

PSC Partners grant cycle is now open! The deadline for your LOI is December 1, 2025

Need help crafting your grant? I offer editing services to help strengthen your proposal. Let's work together to make your work stand out!

pscpartners.org/research/res...

18.08.2025 21:55 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

More #efruxifermin data this time in #MASH F2/F3 fibrosis @ 96 weeks

βœ… Efficacy w/ dose dependent response (sort of) and NITs consistent
↔️ not crazy about mITT though it is mentioned no paired bx= non responders
⬇️ dose dependent reduction in bone mineral density

#liversky

18.08.2025 22:46 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

New hope for #liverhealth: FDA recently approved Wegovy as the 1st #GLP1 therapy for adults with serious #liverdisease. Research presented at TLM β€˜24 demonstrated the groundbreaking treatment potential. Learn more: https://bit.ly/45phv4R

19.08.2025 17:00 β€” πŸ‘ 2    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0
Preview
Endohepatology: Current perspectives and future directions : Hepatology Communications field known as endoscopic hepatology or β€œendohepatology.” This domain integrates endoscopic diagnostic and therapeutic techniques, particularly those which are endoscopic ultrasound–based, into hepato...

journals.lww.com/hepcomm/full...

20.08.2025 01:00 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

When did I start rounding?

06.08.2025 21:22 β€” πŸ‘ 10    πŸ” 0    πŸ’¬ 4    πŸ“Œ 0
Post image Post image Post image Post image

πŸ₯ΎA reboot with endless pearls!

#452 NAFLD/MASLD! Expand your NAFLD/MASLD knowledge!

Expert guest @ebtapper.bsky.social shares his framework for approaching NAFLD/MASLD and the treatment tools he recommends including lifestyle modifications and medications.
www.thecurbsiders.com

04.08.2025 19:34 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

my take on procal:

1. zero role in ED, shouldn't be used to start ABX

2. CAN be super helpful in first 24 hr after ICU admit to help disprove sepsis in complex cases (eg aspiration pneumonitis or atelectasis masquerading as PNA). helps stop ABX & redirect.

3. not helpful in limiting ABX duration

31.07.2025 12:59 β€” πŸ‘ 14    πŸ” 1    πŸ’¬ 2    πŸ“Œ 0
Post image

🚨 High Yield Infographic Alert!

Elevated PTT? Think bleeding history.

🟒 Non-bleeders: APS, contact factor deficiencies, heparin.
πŸ”΄ Bleeders: Hemophilias, vWD, factor VIII inhibitors.

Not all prolonged PTTs mean bleeding risk.

#MedEd #Hematology #FOAMed #ElevatedPTT #TheCurbsiders

16.07.2025 00:57 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
ScienceDirect.com | Science, health and medical journals, full text articles and books.

Another piece of evidence about the role of anticoagulants in cirrhosis. Results of a multicenter effort. The cirroxaban study. @hospitalclinic.bsky.social @idibaps.bsky.social @jhepatology.bsky.social

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

20.07.2025 10:02 β€” πŸ‘ 4    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

Jaume Bosch

No one, and I mean no one, made more seminal contributions to the measurement, interpretation & clinical applications of HVPG, the prognostic impact of CSPH and its rx.

Truly in the pantheon of all time greatest hepatologists and a kind, generous person on top.

RIP

#liversky

17.07.2025 02:54 β€” πŸ‘ 6    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

Then, Fred Paffhausen, as of 3pm today I am definitely a dad enjoying perks

19.07.2025 21:31 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Ask my kids what my goals are - though I am consistent, they will tell you the order is reversed

19.07.2025 20:54 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

LIFE GOALS

1. Raise happy children
2. Be old dude at grand rounds who falls asleep

19.07.2025 20:48 β€” πŸ‘ 23    πŸ” 5    πŸ’¬ 2    πŸ“Œ 1

Daughter wearing a Jean jacket for our day trip to Canada

19.07.2025 12:01 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

I am so sorry for your loss

He was a giant and wonderful man.

15.07.2025 19:15 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

I am very sad. My mentor and friend, Jaume Bosch, just has passed away. Thanks for everything, I will miss you. I would always remember our last day together celebrating a journey we begin together @hospitalclinic.bsky.social @idibaps.bsky.social

15.07.2025 18:02 β€” πŸ‘ 15    πŸ” 5    πŸ’¬ 2    πŸ“Œ 0

There was great enthusiasm for β€œpalliative care” when it was associated with longer survival in lung cancer

However many of trials launched in its wake wrongly assumed that the consult itself was the active ingredient. For PC to help, the consultant needs proven tools to address the symptoms

14.07.2025 00:19 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image Post image

doi:10.1001/jamanetworkopen.2025.19426

14.07.2025 00:19 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image 13.07.2025 20:49 β€” πŸ‘ 6    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0
Post image

Wake up new cause of liver enzyme elevation just dropped

09.07.2025 10:41 β€” πŸ‘ 11    πŸ” 4    πŸ’¬ 1    πŸ“Œ 0
Post image

They are establishing upper limits of normal for ammonia in pets

Thank you for your attention to this matter!

28.06.2025 14:26 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
The Latest in PBC with Gideon Hirschfield Podcast Episode Β· Liver Talks: The Liver Fellow Network Podcast Β· 06/17/2025 Β· 35m

podcasts.apple.com/us/podcast/l...

Gideon is the best of us.

Truly infectious enthusiasm for hepatology

πŸ‘‡ management of pbc
πŸ‘‡ clinical philosophy
πŸ‘‡ how to build a research career

25.06.2025 11:45 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Lightning rounds 53: GI Q&A with Elliot Tapper – Critical Care Scenarios

Recently had @ebtapper.bsky.social on the Critical Care Scenarios podcast talking GI and this topic came up.

icuscenarios.com/lightning-ro...

18.06.2025 11:33 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Cardiovascular risk assessment tools are insufficient for... : Official journal of the American College of Gastroenterology | ACG tudy sought to determine the accuracy of the FRS, PCE, and PREVENT in a real-world cohort of patients with MASLD. Methods: This analysis included US adults β‰₯ age 30 with MASLD in the TARGET-NASH st...

Cardiovascular risk estimates miss the mark in people with MASH

Heart disease is the most important risk for patients with MASH but the commonly used risk equations just don’t work

New paper in the red journal @amcollegegastro.bsky.social

journals.lww.com/ajg/abstract...

15.06.2025 20:09 β€” πŸ‘ 7    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Because the humans make the podcast great

14.06.2025 16:43 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Dear FreelyFiltered

I am a listener of the podcast. I listen for the humans. And their input. I think the AI podcast on the NephJC was a nice as a way for me to hear about a trial and trial discussion I would have missed but the info didnt stick for this adult learner

@kidneyboy.bsky.social

14.06.2025 16:27 β€” πŸ‘ 8    πŸ” 2    πŸ’¬ 1    πŸ“Œ 0

Key points

1. Think about who is at risk for hepatic encephalopathy.
2. Don't anchor on a specific number. Make decisions with the impact on the patient in mind
3. Re-evaluate treatment strategies using patient reported outcomes like quality of life and falls

14.06.2025 16:19 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Here's how I put it together

And if you treat based on poor quality of life you can go back and ask "do you feel better" "are you falling less" and that helps a lot!

(BABS - a score with bilirubin, albumin; OGTT - a physiological test / glutamine challenge)

14.06.2025 16:19 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

@ebtapper is following 18 prominent accounts